why choose us

First received: June 05, 2023

Clinical Trial: REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Anal Cancer

Study Type: INTERVENTIONAL


Official Title: REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation

Brief Summary: To determine the efficacy of reduced elective nodal radiation in anal cancer patients undergoing chemoradiation in reducing toxicity compared to standard nodal irradiation.

Read more